Skip to content

A Clinical Study to Evaluate the A A Effectiveness of Erandadi Taila Ear Oil Therapy in Ear Pain (Diffuse Otitis Externa)

Randomized Open Controlled Clinical Study To Evaluate The Efficacy Of Erandadi Taila Karnapooran In Karnashoola w.s.r. To Diffuse Otitis Externa - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101291
Enrollment
80
Registered
2026-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H603- Other infective otitis externa

Interventions

None listed

Sponsors

Dr Gayatri Rajendra Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having sign and symptoms of Karnashoola w.s.r. Diffuse Otitis Externa 2) Patients between 18 to 60 years of age group, irrespective of gender, caste, religion, economical class, race. 3) patient with unilateral or bilateral Karnashoola 4) Patient having Intact tympanic membrane

Exclusion criteria

Exclusion criteria: 1) Patient other than Karnashoola w.s.r. Diffuse Otitis Externa will be excluded 2) Patient with known history any systemic disorder with complication which can lead to interference with study 3) Patient with having congenital anomalies of ear like Anotia, Microtia, Cryptotia, & Atresia of External canal 4) Patient with Tympanic membrane perforation

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Erandadi Taila Karnapooran in Karanshoola w.s.r. Diffuse Otitis ExternaTimepoint: To evaluate the efficacy of Erandadi Taila Karnapooran in Karanshoola w.s.r. Diffuse Otitis Externa

Secondary

MeasureTime frame
1 To Assess the reduction in associated symptom such as Karnakandu Itching in patients of diffuse otitis externa after 15 days of Erandadi Taila Karnapooran 2 To Assess the reduction in associated symptom such as karnastrav Ear Dischargein patients of diffuse otitis externa after 15 days of Erandadi Taila Karnapooran 3 To Assess the reduction in associated symptom such as meatal skin colour in patients of diffuse otitis externa after 15 days of Erandadi Taila Karnapooran 4 To evaluate the tolerability & safety profile of Erandadi Taila when administered as Karnapooran over a treatment duration of 15 consecutive days 5 To compare the recurrence rate of Karnashoola within 30 days posttreatment between the Erandadi Taila group & the Hingwadi taila 6 To Achieve Outcome of study in 30 daysTimepoint: Randomized Open Controlled Clinical Study To Evaluate The Efficacy Of Erandadi Taila Karnapooran In Karnashoola w.s.r. To Diffuse Otitis externa

Countries

India

Contacts

Public ContactDr Swati Bele

Yashwant Ayurvedic Medical College PGT and RC Kodoli

swativbele@gmail.com9765787111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026